Format

Send to

Choose Destination
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):286-291. doi: 10.1097/MPG.0000000000001460.

Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet.

Author information

1
*Department of Pediatric Gastroenterology and Nutrition, MassGeneral Hospital for Children†Celiac Research Program, Harvard Medical School‡Division of Gastroenterology and Nutrition§Clinical Research Center, Boston Children's Hospital||Department of Medicine, Massachusetts General Hospital, Boston, MA¶University of Manitoba, Winnipeg, Manitoba, Canada.

Abstract

OBJECTIVES:

Our objective was to determine the rate of mucosal recovery in pediatric patients with celiac disease on a gluten-free diet. We also sought to determine whether immunoglobulin A tissue transglutaminase (tTG) correlates with mucosal damage at the time of a repeat endoscopy with duodenal biopsy in these patients.

METHODS:

We performed a retrospective chart review of 103 pediatric patients, younger than 21 years, with a diagnosis of celiac disease defined as Marsh 3 histology, and who underwent a repeat endoscopy with duodenal biopsy at least 12 months after initiating a gluten-free diet.

RESULTS:

We found that 19% of pediatric patients treated with a gluten-free diet had persistent enteropathy. At the time of the repeat biopsy, tTG was elevated in 43% of cases with persistent enteropathy and 32% of cases in which there was mucosal recovery. Overall the positive predictive value of the autoantibody tTG was 25% and the negative predictive value was 83% in patients on a gluten-free diet for a median of 2.4 years.

CONCLUSIONS:

Nearly 1 in 5 children with celiac disease in our population had persistent enteropathy despite maintaining a gluten-free diet and immunoglobulin A tTG was not an accurate marker of mucosal recovery. Neither the presence of symptoms nor positive serology were predictive of a patient's histology at the time of repeat biopsy. These findings suggest a revisitation of monitring and management criteria of celiac disease in childhood.

Comment in

PMID:
28112686
PMCID:
PMC5457911
DOI:
10.1097/MPG.0000000000001460
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center